Cells with amplified HER2 gene have to be considered carefully, study says Biocept, Inc estrogen impact ., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells and circulating tumor DNA in malignancy patients, reported the publication in the journal Cancer tumor Medication of a paper entitled ‘Discordance in HER2 gene amplification in circulating and disseminated tumor cells in sufferers with operable breast tumor’ on study performed with collaborators from the University of Texas MD Anderson Malignancy Center.
Cell’s cytoskeleton may hold key to overcoming drug resistance in cancer Researchers have got uncovered a new manner in which a cell proteins protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients. A team of scientists at Children’s Cancer Institute Australia for Medical Analysis , led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin element of the cell’s cytoskeleton could play a significant role in level of resistance to an array of drugs used to treat lung, ovarian and breast cancers. Advanced non-little cell lung carcinomas account for more than 80 per cent of lung cancer instances. More than one million people are identified as having lung cancer every full year, the most common cancer in the globe and the leading reason behind cancer deaths.